FDA guidance about improving diversity in studies has gained momentum and continues to do so. It has always been a goal of nearly every clinical research professional, but achieving it has been historically difficult, how has this changed since the guidance...
Measuring potency for gene and cell therapies is not so clear-cut, and some companies have hit roadblocks in their submissions to regulatory agencies as a result. This webinar will look at ways to overcome that hurdle as well as challenges in relation...
Innovations in drug delivery never stop and constant progress continues way past the oral route with the development of implants, patches, syringes as well as solutions for transdermal, topical, and oral drug delivery systems that target diseases, provide...
"Patient centricity" is more than just a catchphrase in today's drug development industry. However, sites and sponsors still struggle with what it means to be truly patient centric. This webinar will gather leading minds to discuss how...
Putting the patient first is an oft-stated goal of clinical trial professionals, but that goal is not often met in studies. This online event will get into what it truly means to be patient centric, new and emerging technologies that improve engagement,...
Taking patient interactions from trial sites to off-site is more than just a change of geography. Virtual trial success involves intelligent planning, effective data collection and management tools, advanced patient engagement technology, and more.
Next-level technology is transforming the process from the early end of the process to later stages of clinical development. This special edition will share innovations impacting drug discovery (such as artificial intelligence and machine learning, remote...
While some diseases only impact a small percentage of the population, these unique patients still need treatments and therapies. This online event will discuss the needs of such special patients, how researchers can address recruitment and enrollment,...
This editorial webinar will explore advancements in technology that are changing the way we view clinical trials, including remote monitoring solutions, AI and more.
In this editorial webinar, we bring together leading experts to discuss what major trends are occurring across the industry in the development of new methods of drug delivery, as well as improvements to existing ones. We aim to inform the listeners of...
The term “special population” exists to protect certain vulnerable patient groups that require additional consideration as it pertains to clinical research, including women, pediatrics, and the elderly.
Artificial intelligence (AI) is the industry’s latest buzzword and is being touted as the solution to myriad problems. So where will it have the biggest impact across the drug development continuum? From identifying repurposable drugs, to mining data...
